National Institute of Allergy and Infectious Diseases (NIAID)
10
Glaxo Wellcome
3
University of California, Los Angeles
1
Clinical Trials at Addiction Research and Treatment Corp
During the past decade, Addiction Research and Treatment Corp conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection
A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women
A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients
Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection
1996-06-01
Completed
600
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Addiction Research and Treatment Corp"
#1 collaborator was "Glaxo Wellcome" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Warner Lambert - Parke Davis" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Addiction Research and Treatment Corp
According to Clinical.Site data, the most researched conditions in "Addiction Research and Treatment Corp" are
"HIV Infections" (13 trials), "Tuberculosis" (4 trials), "Candidiasis" (2 trials), "Candidiasis, Esophageal" (1 trials) and "Cytomegalovirus Retinitis" (1 trials). Many other conditions were trialed in "Addiction Research and Treatment Corp" in a lesser frequency.
Clinical Trials Intervention Types at Addiction Research and Treatment Corp
Most popular intervention types in "Addiction Research and Treatment Corp" are "Drug" (13 trials). Other intervention types were less common.
The name of intervention was led by "Abacavir sulfate" (3 trials), "Fluconazole" (2 trials), "Isoniazid" (2 trials), "Lamivudine/Zidovudine" (2 trials) and "Pyridoxine hydrochloride" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Addiction Research and Treatment Corp
The vast majority of trials in "Addiction Research and Treatment Corp" are
13 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Addiction Research and Treatment Corp
Currently, there are NaN active trials in "Addiction Research and Treatment Corp".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in Addiction Research and Treatment Corp,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Addiction Research and Treatment Corp, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 5 trials that are defined as “Not Applicable".